Washington, DC 20549
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 2, 2017 (August 1, 2017)
Owens & Minor, Inc.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
of incorporation
File Number)
(IRS Employer
Identification No.)
9120 Lockwood Blvd., Mechanicsville, Virginia
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (804) 723-7000
Not applicable
(former name or former address, if changed since last report.)

 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company    o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.             o

Item 2.02
Results of Operations and Financial Condition.

On August 1, 2017, Owens & Minor, Inc. (the “Company”) issued a press release regarding its financial results for the second quarter ended June 30, 2017. The Company is furnishing the press release attached hereto as Exhibit 99.1 pursuant to Item 2.02 of Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 8.01
Other Events.
On August 1, 2017, Owens & Minor, Inc. (the “Company”) and through two wholly-owned subsidiaries, Barista Acquisition I, LLC and Barista Acquisition II, LLC (collectively, the “Acquisition Subs”), completed the previously announced acquisition of all of the partnership interests of Mediq USA Holdings (“Mediq USA”), the owner of Byram Healthcare, a national leader in disposable medical supply delivery (“Byram”), in accordance with the Interest Purchase Agreement, dated as of May 2, 2017, by and among the Company, the Acquisition Subs, Mediq USA, Mediq B.V. and Mediq International B.V. and filed with the Securities and Exchange Commission as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2017 dated May 3, 2017.

Item 9.01
Financial Statements and Exhibits.
(c) Exhibits.
Press Release issued by the Company on August 1, 2017

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: August 2, 2017
/s/ Nicholas J. Pace
Nicholas J. Pace
Senior Vice President, General Counsel and Corporate Secretary

Exhibit Index
Exhibit No.
Press Release issued by the Company on August 1, 2017